Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics and chronic inflammatory bowel diseases.

Emanuela Felley-Bosco1, Muriel André

  • 1Institute of Pharmacology and Toxicology, Rue du Bugnon 27, Lausanne 1005, Switzerland. emanuela.felley-bosco@ipharm.unil.ch

Pathology, Research and Practice
|July 9, 2004
PubMed
Summary

This review explores proteomics technologies and metabolic changes in inflammatory bowel diseases (IBD). It details how these methods help understand the molecular mechanisms driving IBD development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Asbestos and disease genomics: is mesothelioma a genomic paradigm?

Frontiers in toxicology·2025
Same author

Evaluation of Spliceosome Protein SmD2 as a Potential Target for Cancer Therapy.

International journal of molecular sciences·2024
Same author

Carcinogenicity of talc and acrylonitrile.

The Lancet. Oncology·2024
Same author

Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing.

Cancers·2023
Same author

Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy.

Cancers·2023
Same author

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma.

International journal of molecular sciences·2023

Area of Science:

  • Gastroenterology and Immunology
  • Proteomics and Metabolomics

Background:

  • Inflammatory bowel diseases (IBD) are prevalent in developed nations.
  • IBD pathogenesis involves immune, mesenchymal, and epithelial cell activation.
  • Understanding IBD molecular mechanisms is crucial for effective treatment.

Purpose of the Study:

  • To provide an overview of current proteomics technologies for IBD research.
  • To describe metabolic alterations associated with IBD.
  • To explore the application of proteomics in elucidating IBD molecular mechanisms.

Main Methods:

  • Review of existing literature on proteomics and IBD.
  • Analysis of metabolic changes reported in IBD studies.
  • Discussion of proteomics-based approaches for mechanistic insights.

Related Experiment Videos

Main Results:

  • Proteomics offers powerful tools for IBD investigation.
  • Metabolic dysregulation is a key feature of IBD.
  • Proteomics aids in identifying molecular players in IBD pathogenesis.

Conclusions:

  • Proteomics is instrumental in advancing IBD research.
  • Understanding metabolic changes through proteomics can reveal disease pathways.
  • This approach facilitates the discovery of novel therapeutic targets for IBD.